Author

Hadi Bayat

PhD, Molecular Genetics - Cited by 447 - Genome editing - RNA-Decoys - Monoclonal Abs - Neurogenetics

Biography

Dr. Hadi Bayat is an associate professor working in Medical Nano-Technology & Tissue Engineering Research Center at Shahid Beheshti University of Medical Sciences in Tehran at Iran and he also works at Department of Tissue Engineering and Regenerative Medicine, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Title
Cited by
Year
Duchenne Muscular Dystrophy (DMD) An updated review of common available therapies
A Salmaninejad, S Farajzadeh Valilou, H Bayat, N Ebadi, A Daraei, ...International Journal of Neuroscience, 2018201
57
2018
The conspicuity of CRISPR-Cpf1 system as a significant breakthrough in genome editing
H Bayat, MH Modarressi, A RahimpourCurrent microbiology 75, 107-115, 2018201
47
2018
The XmnI and BCL11A Single Nucleotide Polymorphisms May Help Predict Hydroxyurea Response in Iranian β-Thalassemia Patients
M Banan, H Bayat, A Azarkeivan, S Mohammadparast, K Kamali, ...Hemoglobin 36 (4), 371-380, 2012201
44
2012
Humanizing glycosylation pathways in eukaryotic expression systems
AH Khan, H Bayat, M Rajabibazl, S Sabri, A RahimpourWorld journal of Microbiology and Biotechnology 33 (4), 1-12, 2017201
44
2017
Exceptional expansion and conservation of a CT‐repeat complex in the core promoter of PAXBP1 in primates
S Mohammadparast, H Bayat, A Biglarian, M OhadiAmerican journal of primatology 76 (8), 747-756, 2014201
40
2014
Polymorphic core promoter GA-repeats alter gene expression of the early embryonic developmental genes
E Valipour, A Kowsari, H Bayat, M Banan, S Kazeminasab, ...Gene 531 (2), 175-179, 2013201
34
2013
Evaluation of different vector design strategies for the expression of recombinant monoclonal antibody in CHO cells
H Bayat, S Hoseinzadeh, E Pourmaleki, R Ahani, A RahimpourPreparative biochemistry & biotechnology 48 (2), 160-164, 2018201
27
2018
Common therapeutic advances for Duchenne muscular dystrophy (DMD)
A Salmaninejad, Y Jafari Abarghanb, S Bozorg Qomib, H Bayat, ...International Journal of Neuroscience, 1-21, 2020202
24
2020
The Impact of CRISPR-Cas System on Antiviral Therapy
H Bayat, F Naderi, A Hayat Khan, A Memarnejadian, A RahimpourAdvanced Pharmaceutical Bulletin, 2018201
22
2018
The CRISPR growth spurt: from bench to clinic on versatile small RNAs
H Bayat, M Omidi, M Rajabibazl, S Sabri, A RahimpourJournal of Microbiology and Biotechnology 26 (9), 2016201
19
2016
Utility of the multivariate approach in predicting β-thalassemia intermedia or β-thalassemia major types in Iranian patients
M Banan, H Bayat, P Namdar-Aligoodarzi, A Azarkeivan, K Kamali, ...Hemoglobin 37 (5), 413-422, 2013201
14
2013
Overexpression of VEGF in dermal fibroblast cells accelerates the angiogenesis and wound healing function: in vitro and in vivo studies
F Shams, H Moravvej, S Hosseinzadeh, E Mostafavi, H Bayat, B Kazemi, ...Scientific Reports , 2022202
12
2022
Investigation of rs531564 polymorphism in the primary microRNA-124 gene in patients with systemic lupus erythematosus and rheumatoid arthritis: association with disease …
Investigation of rs531564 polymorphism in the primary microRNA-4 gene in patients with systemic lupus erythematosus and rheumatoid arthritis: association with disease …M Hassani, M Dehani, MZ Rafie, E Esmaeilzadeh, S Davar, B Pakzad, ...Iranian Journal of Allergy, Asthma and Immunology 20 (3), 303-313, 2021202
12
2021
Association study of IL-4-590 C/T and DDX39B-22 G/C polymorphisms with the risk of late-onset alzheimer’s disease in Iranian population
Association study of IL-4-50 C/T and DDX3B-22 G/C polymorphisms with the risk of late-onset alzheimer’s disease in Iranian populationM Soosanabadi, H Bayat, K Kamali, K Saliminejad, M Banan, ...Current aging science 8 (3), 276-281, 2015201
9
2015
The augmenting effects of the tDNA insulator on stable expression of monoclonal antibody in Chinese hamster ovary cells
F Naderi, M Hashemi, H Bayat, O Mohammadian, E Pourmaleki, ...Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 37 (5), 200-206, 20120
8
2018
Development of an improved lentiviral based vector system for the stable expression of monoclonal antibody in CHO cells
O Mohammadian, M Rajabibazl, E Pourmaleki, H Bayat, R Ahani, ...Preparative Biochemistry and Biotechnology, 2019201
8
2019
Stable expression of anti-CD52 monoclonal antibody using a bicistronic vector system
H Bayat, M Omidi, M Peyrovan, O Mohammadian, F Naderi, A RahimpourBiology and Medicine 8 (), 1, 2016201
7
2016
Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives
APK Ali Dehshahri, Alessio Biagioni, Hadi Bayat, E Hui Clarissa Lee ...International Journal of Molecular Sciences 22 (21), 11321, 2021202
6
2021
Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems
F Shams, H Bayat, O Mohammadian, S Mahboudi, H Vahidnezhad, ...BioImpacts: BI 12 (4), 371, 2022202
5
2022
Dysregulation of long noncoding RNA MEG3 and NLRC5 expressions in patients with relapsing-remitting multiple sclerosis: is there any correlation?
S Torkamandi, S Bahrami, T Ghorashi, M Dehani, H Bayat, SM Hoseini, ...Genes & Immunity 22 (7-8), 322-326, 2021202
4
2021

Referred From: https://scholar.google.ca/citations?user=fNNi33gAAAAJ&hl=en

Cited by
Citations 447
h-index 12
i10-index 13
Recommended Journals
Open Access Journals